Oregon Health & Science University donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Facebook page OHSUedu
Websitehttp://www.ohsu.edu/xd
Twitter usernameOHSUNews
Wikipedia pagehttps://en.wikipedia.org/wiki/Oregon_Health_%26_Science_University

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 29 1,000,000 2,696,841 -22,676 100,000 110,000 398,238 599,999 1,000,000 2,071,166 2,956,358 4,231,660 4,999,999 25,020,336
Global health 18 1,000,000 3,333,959 -22,676 100,000 100,000 398,238 999,998 1,000,000 2,871,805 2,956,358 4,832,375 7,958,944 25,020,336
Family planning 4 295,046 1,501,204 100,000 100,000 100,000 295,046 295,046 295,046 609,772 609,772 4,999,999 4,999,999 4,999,999
Nutrition 3 599,999 1,236,260 110,000 110,000 110,000 110,000 599,999 599,999 599,999 2,998,782 2,998,782 2,998,782 2,998,782
Health 3 1,582,837 1,417,294 597,880 597,880 597,880 597,880 1,582,837 1,582,837 1,582,837 2,071,166 2,071,166 2,071,166 2,071,166
New Initiatives 1 4,231,660 4,231,660 4,231,660 4,231,660 4,231,660 4,231,660 4,231,660 4,231,660 4,231,660 4,231,660 4,231,660 4,231,660 4,231,660

Donation amounts by donor and year for donee Oregon Health & Science University

Donor Total 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Bill and Melinda Gates Foundation (filter this donee) 69,724,855.36 5,032,199.00 1,008,010.38 8,714,559.98 2,956,358.00 38,477,935.00 3,166,851.00 1,999,998.00 8,068,944.00 100,000.00 100,000.00 100,000.00
Laura and John Arnold Foundation (filter this donee) 8,483,543.00 0.00 2,669,046.00 5,814,497.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total 78,208,398.36 5,032,199.00 3,677,056.38 14,529,056.98 2,956,358.00 38,477,935.00 3,166,851.00 1,999,998.00 8,068,944.00 100,000.00 100,000.00 100,000.00

Full list of donations in reverse chronological order (29 donations)

DonorAmount (current USD)Amount rank (out of 29)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation4,832,375.0052018-09-25Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide fundamental research on a new type of vaccine-elicited CD8+ T cell immunity with the potential to control and clear HIV, and therefore to enable development of a safe and effective HIV/AIDS vaccine for use in high burden countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation199,824.00232018-04-11Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to explore the potential for MAIT cell targeted vaccination to prevent TB. Targeting MAIT cells for TB vaccines. Investment start date: 10/26/2015 to end date: 4/30/2019. Grantee name: Oregon Health & Science University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation398,238.00212017-11-20Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to explore the ability of anti-Mycobacterium tuberculosis nanobodies to penetrate granulomas; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation609,772.38172017-10-30Family planninghttps://iatiregistry.org/publisher/bmgf-- to develop a new class of novel, orally active non-hormonal candidates and perform initial pre-clinical evaluations to provide preliminary data for the approach as an on-demand contraceptive method for women; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Laura and John Arnold Foundation2,071,166.00122017Healthhttp://www.arnoldfoundation.org/grants/-- Grant period: 2017 - 2020. Affected countries: United States; affected states: Oregon.
Laura and John Arnold Foundation597,880.00192017Healthhttp://www.arnoldfoundation.org/grants/-- Grant period: 2017 - 2018. Affected countries: United States; affected states: Oregon.
Bill and Melinda Gates Foundation2,886,767.00102016-11-11Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to determine if vaccination can reduce Campylobacter infection and environmental enteric dysfunction (EED), thereby improving gut health while increasing infant growth trajectories; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-22,676.02292016-07-28Global health/Reproductive health carehttps://iatiregistry.org/publisher/bmgf-- To hold an international summit in May 2015 for nutrition scientists and developing country program implementers, to encourage dialogue and collaboration for the purpose of improving preconception and maternal nutritional status among adolescent girls and; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,303,692.00142016-06-15Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to support pre-clinical and early clinical development of a novel TB vaccine for use in high burden countries in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,946,778.0072016-03-09Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to accelerate the testing of the prototype(s) live attenuated CMV based HIV vaccine in first in human experimental medicine trial; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation599,999.00182016-03-08Nutrition/basic nutritionhttps://iatiregistry.org/publisher/bmgf-- to develop and characterize a non-human primate (NHP) model of environmental enteric dysfunction (EED) that can be used to down-select and de-risk potential preventative and therapeutic interventions; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Laura and John Arnold Foundation4,231,660.0062016New Initiativeshttp://www.arnoldfoundation.org/grants/-- Grant period: 2016 - 2019. Affected countries: United States; affected states: Oregon.
Laura and John Arnold Foundation1,582,837.00132016Healthhttp://www.arnoldfoundation.org/grants/-- Grant period: 2016 - 2017. Affected countries: United States; affected states: Oregon.
Bill and Melinda Gates Foundation2,956,358.0092015-10-26Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to explore the potential for MAIT cell targeted vaccination to prevent TB. Targeting MAIT cells for TB vaccines. Investment start date: 10/26/2015 to end date: 4/30/2019. Grantee name: Oregon Health & Science University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,999,999.0032014-11-04Family planninghttps://iatiregistry.org/publisher/bmgf-- to develop additional safe, effective, acceptable and accessible methods of permanent or very long-acting contraception that will fill an unmet need for women who have reached their desired family size and do not wish to become pregnant again; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00252014-10-22Global health/basic health carehttps://iatiregistry.org/publisher/bmgf-- to identify pre- and early post-natal biomarkers that can predict the later aberrant development of certain cognitive functions important for many social and academic skills, to enable early treatment; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,938,923.0042014-09-22Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide fundamental research on a new type of vaccine-elicited CD8+ T cell immunity with the potential to control and clear HIV, and therefore to enable development of a safe and effective HIV/AIDS vaccine for use in high burden countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,998,782.0082014-09-05Nutrition/basic nutritionhttps://iatiregistry.org/publisher/bmgf-- To better understand the mechanisms linking maternal nutrition and child health, we propose to establish a multidisciplinary team of experts to develop a new highly relevant and translational nonhuman primate (NHP) model in which to systematically dissect; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation25,020,336.0012014-07-28Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to accelerate the testing of the prototype(s) live attenuated CMV based HIV vaccine in first in human experimental medicine trial; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation419,895.00202014-07-18Global health/Reproductive health carehttps://iatiregistry.org/publisher/bmgf-- To hold an international summit in May 2015 for nutrition scientists and developing country program implementers, to encourage dialogue and collaboration for the purpose of improving preconception and maternal nutritional status among adolescent girls and; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,871,805.00112013-10-08Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support CMV vector-based Vaccine Concept. CMV vector-based Vaccine Concept. Investment start date: 10/8/2013 to end date: 4/30/2016. Grantee name: Oregon Health & Science University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation295,046.00222013-06-26Family planninghttps://iatiregistry.org/publisher/bmgf-- to support preparation leading to the development of a plan for a research center of excellence devoted to the development of a voluntary low-cost, highly acceptable, and easily administered non-surgical method of permanent female contraception; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,000,000.00152012-08-14Global health/Reproductive health carehttps://iatiregistry.org/publisher/bmgf-- to further test the feasibility of using the varicose vein treatment polidocanol in a foam format as a potential method of permanent contraception; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation999,998.00162012-04-06Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to target T-cells against ERV antigens. If true, new host-directed vaccines could be developed to eliminate HIV infected cells.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation7,958,944.0022011-09-15Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop a safe and effective CMV/HIV vaccine that will fully exploit the early vulnerability of HIV infection to potent effector-memory T cell responses, and will be suitable for clinical translation; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation110,000.00242011-06-24Nutrition/basic nutritionhttps://iatiregistry.org/publisher/bmgf-- for conference support. DOHAD Conference Grant. Investment start date: 6/24/2011 to end date: 12/31/2011. Grantee name: Oregon Health and Science University Foundation; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00252010-09-22Family planninghttps://iatiregistry.org/publisher/bmgf-- to test the feasibility of using the varicose vein treatment polidocanol to permanently close fallopian tubes, offering a low-cost, nonsurgical sterilization method for administration by minimally trained healthcare workers in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00252009-10-07Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to target T-cells against these ERV antigens. If true, new host-directed vaccines could be developed to eliminate HIV infected cells.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00252008-09-03Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to work to design components of an HIV vaccine using groups of related envelope sequences.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.